Formoterol Fumarate
<p>Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study</p>
... glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) is a triple fi xed-dose combination of an ICS, a LAMA, and a LABA formulated using co-suspension delivery technology that is currently in ...
13
<p>Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD</p>
... nide/glycopyrrolate/formoterol fumarate metered dose inha- ler (BGF MDI), which is formulated using co-suspension delivery ...copyrrolate/formoterol fumarate (GFF) MDI or budesonide/ ...
10
Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study
... budesonide/formoterol fumarate (BFF) MDI and glyco- pyrrolate/formoterol fumarate (GFF) MDI on bone mineral density (BMD) and ocular safety over 52 ...
14
Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD
... A randomized, seven‑day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed‑dose combination metered dose inhaler using novel Co‑Suspension™ D[r] ...
13
DEVELOPMENT OF REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD AND ITS VALIDATION FOR ESTIMATION OF FORMOTEROL FUMARATE ROTA CAPS
... Preparation: Weigh 100 Formoterol Fumarate Rotacaps and calculate the average weight. Remove the capsule shells and accurately weigh and transfer the content of test substance into a 10mL volumetric flask. ...
6
STABILITY INDICATING HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY METHOD FOR SIMULTANEOUS ESTIMATION OF FORMOTEROL FUMARATE DIHYDRATE AND FLUTICASONE PROPIONATE IN BULK DRUG AND PHARMACEUTICAL DOSAGE FORM
... Inhalation is currently the preferred route of drug delivery in asthma in accordance with a global initiative for asthma guideline [1], as it allows the release of drug directly to the site where the action is needed, ...
7
UV Spectrophotometric Method for Simultaneous Estimation of Glycopyrrolate and Formoterol Fumarate in Their Synthetic Mixture by Absorbance Correction Method
... Reference standard of Glycopyrrolate and Formoterol Fumarate were received as gift sample from Glenmark Pharmaceuticals (Mumbai). Methanol AR grade was purchased from Ahmedabad, India. UV Visible ...
11
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
... or formoterol fumarate (a LABA) 12 μ g twice daily improves lung function and reduces COPD symptoms while being well tolerated ...bromide/formoterol fumarate (Genuair ® / Pressair ® *, ...
18
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial
... Background: A clinical trial of mometasone furoate/formoterol fumarate (MF/F) administered via a metered-dose inhaler in subjects with moderate to very severe chronic obst[r] ...
13
<p>Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap</p>
... of data from studies of asthma or chronic obstructive pulmonary disease (COPD) alone. Methods: A 12-week, randomized, open-label cross-over pilot study was conducted in 19 patients with ACO to investigate the effect of ...
9
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease
... MDI 7.2 μg BID; (vi) placebo MDI BID; (vii) FF DPI 12 μg BID; and (viii) tiotropium DPI 18 μg QD. In this report, GP was expressed as glycopyrrolate (also known as glycopyrro- nium bromide) for which ex-actuator doses of ...
13
Simultaneous Estimation of Formoterol Fumarate Dihydrate and Fluticasone Propionate in Dry Powder Inhalation Formulation by HPTLC
... Formoterol fumarate dihydrate was a kind gift of Vasmi Labs Ltd. (Solapur, India) and Fluticasone propionate was provided by Aarti Industries Ltd. Palghar, (Thane, India). Pharmaceutical formulation of ...
6
<p>Cost versus utility of aclidinium bromide 400 μg plus formoterol fumarate dihydrate 12 μg compared to aclidinium bromide 400 μg alone in the management of moderate-to-severe COPD</p>
... plus formoterol fumarate dihy- drate 12 µg is a combination of two bronchodilators – aclidinium bromide 400 µg (a long-acting muscarinic antagonist [LAMA]) and formoterol fumarate dehydrate 12 ...
12
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
... This article reviews the available evidence of the efficacy of triple therapy in COPD. We review studies using extem- porary triple therapy (ie, therapy delivered through separate inhalers with different posologies), ...
12
Method development and validation of simultaneous estimation of glycopyrrolate and formoterol fumarate in its bulk form by RP-HPLC
... of formoterol fumarate were weighed into a 100 ml volumetric flask, to this 70ml of mobile phase was added, sonicated and the volume was made up with the mobile ...
7
STABILITY INDICATING HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF MOMETASONE FUROATE AND FORMOTEROL FUMARATE IN COMBINED DOSAGE FORM
... of formoterol fumarate and mometasone furoate using a Enamal C18 column and a mobile phase composed of acetonitrile: ...of formoterol fumarate and mometasone furoate found to be ...of ...
12
Spotlight on glycopyrronium/formoterol fumarate inhalation aerosol in the management of COPD: design, development, and place in therapy
... Glycopyrronium/formoterol fumarate fixed-dose combination formulated in a familiar metered-dose inhaler format using proprietary co-suspension technology is a new option on the ...
6
<p>Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies</p>
... Patients received 24 weeks of treatment with GFF MDI 18/9.6 µg, glycopyrrolate (GP) MDI 18 µg, formoterol fumarate (FF) MDI 9.6 µg, or placebo MDI twice daily in all studies. PINNACLE-1 included an ...
8
VALIDATED METHOD DEVELOPMENT FOR ESTIMATION OF FORMOTEROL FUMARATE AND MOMETASONE FUROATE IN METERED DOSE INHALATION FORM BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
... of formoterol fumarate and mometasone furoate under liquid and solid stress conditions (acid, base hydrolysis and oxidation, thermal, UV and humidity), to show that formoterol fumarate and ...
6
Development and Validation of Analytical Method for Simultaneous Estimation of Formoterol Fumarate Dihydrate and Fluticasone Propionate from Bulk and Dry Powder Inhaler Formulation
... of Formoterol Fumarate Dihydrate & Fluticasone Propionate in dry powder Inhalation formulation, without any interference from the ...for Formoterol Fumarate Dihydrate & Fluticasone ...
11